Free interactive COVID-19 drug interaction checker

And recommendations for interactions with experimental COVID-19 therapies

Those most susceptible to the worst outcomes of COVID-19 are the immunocompromised and with underlying comorbidities, posing a risk for drug-drug interactions (DDIs). See the interactions checker and free prescribing resources to aid the use of experimental agents in the ... Read more

Statement from IUPHAR in Response to the COVID-19 Pandemic

International Union of Basic and Clinical Pharmacology

Warnings on self-medication / stopping medicines; pharmacological considerations in older people; medication errors, interactions & ADRs; off-label use; supply management; misleading claims / fraud; & clinical research Read more

Model-informed Drug Repurposing - Applications for COVID-19

Pharmacometrics Africa and Certara

This webinar covered the importance of integrating clinical pharmacology and translational medicine principles in COVID-19 dosing strategy and study design with a demonstration of PKPD simulation tools available on using recently completed analyses for ivermectin, chloroquine, and lopinavir/ritonavir Read more

WHO Pharmaceuticals Newsletter

Including summary of HYDROXYCHLOROQUINE case safety reports in Vigibase

Dissemination of information on the safety and efficacy of pharmaceutical products, based on information received from the WHO's network of "drug information officers", bulletins and journals etc. Read more

Free eLearning about ADRs from UK MHRA

Adverse Drug Reactions: reporting makes medicines safer

The module was developed as part of the SCOPE Joint Action project to raise awareness levels of ADR reporting. You are requested to complete a short survey upon completion of the free e-learning. Read more

Featured Pharmacovigilance Resource

Freely available quality training and tools

Six modules about Adverse Drug Reactions developed by NHS Education for Scotland and the Yellow Card Centre Scotland (Centre for Adverse Reactions to Drugs Scotland); their incidence & public health implications, the different classifications of ADRs & drug allergies, how ... Read more

ISoP Mid-Year Training Course 2019 - A Report

Read more about the Mid-Year Symposium, Nairobi, Kenya, and the call for ASoP volunteers

The International Society of Pharmacovigilance’s (ISoP’s) held a Mid-Year Symposium and Training Course in Nairobi, Kenya brining together nearly 100 ISoP members from across Africa and beyond, including from government/regulatory bodies, the pharmaceutical industry and academia. The event concluded with ... Read more

Share your Pharmacovigilance Story

Inspire someone to consider post-graduate studies or a job in pharmacovigilance

We have a growing list of articles detailing personal experiences of post-graduate study or working in pharmacovigilance. This is intended to inspire others who may be considering their own PV journey. Would you like to be featured? We'd love to ... Read more


Two EDCTP-funded pharmacovigilance consortia

PAVIA and PROFORMA are two large, coordinated, African pharmacovigilance consortia that are part of the EDCTP2 programme supported by the European Union’s Horizon 2020 research and innovation programme Read more

WHO Pharmacovigilance Toolkit

The new WHO PV Toolkit comprises resources and information for the practice of pharmacovigilance, with a special focus on low- and middle-income countries. Read more

Revision 4 ENCePP Code of Conduct

A new ENCePP Code of Conduct provides a set of rules and principles for pharmacoepidemiology and pharmacovigilance studies to promote scientific independence and transparency throughout the research process. Read more

News Archive

Can't find what you're looking for? You can browse news items previously featured on our home page in our News Archive! Read more